<DOC>
	<DOCNO>NCT03070405</DOCNO>
	<brief_summary>The main purpose study evaluate whether PAS change PK parameter tenofovir .</brief_summary>
	<brief_title>The Effect PAS Pharmacokinetics Tenofovir Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Aminosalicylic Acid</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>1 . Healthy adult male volunteer , age 19 45 year time screen test inclusive . 2 . Subjects congenital chronic disease sign symptom medical examination 3 . Body Mass Index ( BMI ) 18 25 kg/m2 , inclusive . BMI = weight ( kg ) / [ height ( ) ] 2 . 4 . Volunteers deem appropriate subject investigator , pass medical screening , include assessment medical history , vital sign , 12lead ECG , physical examination , laboratory test etc . accord characteristic investigational product . 5 . Subjects participate whole clinical trial . 6 . Subjects voluntarily sign write consent form receive information regard objective content trial , characteristic study drug drug prior sign . 1 . Medical History 1 . Subjects disease history clinically significant liver , kidney , digestive system , respiratory system , musculoskeletal system , endocrine system , neuropsychiatric system , hematooncologic system , urinary system , cardiovascular system include arrhythmia . 2 . Subjects history gastrointestinal diseases/conditions could impact absorption study drug . 2 . Laboratory Test ECG Findings 1 . Subjects show , clinical abnormality detect laboratory test prior trial commencement date . Criteria liver renal function test show : AST ALT 1.25×ULN Total bilirubin 1.5×ULN Serum creatinine clearance calculate CKDEPI 80mL/min 2 . Subjects show clinically significant abnormality detect ECG 3 . History hypersensitivity drug include study drug ingredient medication ( aspirin , antibiotic , etc . ) clinically significant hypersensitivity 4 . Prohibition Concomitant Drug/Food 1 . Use ethicalthecounter/herbal preparation use overthecounter medications/vitamin medication within 2 week 1 week prior study drug administration , respectively 2 . Subjects diet could affect study drug 's pharmacokinetics 3 . Subjects administer Probenecid , Penicillin G drug already know effect OAT1 Transporter activity within 2 week prior first dose . 5 . Blood Donation Transfusion 1 . Donation blood plasma blood bank clinical study ( except screen visit ) within 60 day prior study drug administration . 2 . Blood transfusion within 30 day prior study drug administration . 6 . Other Exclusion Criteria 1 . Alcohol intake ( alcohol &gt; 30g/day ) screen positive alcohol 2 . Subjects smoke within 3 month initiation clinical trial subject stop smoke participation clinical study 3 . Subjects stop take caffeinecontaining food ( e.g . coffee , tea , green tea , cocoa , chocolate , soda , coffee milk , energy supplementary beverage , etc . ) alcoholic beverage participation clinical study 4 . Subjects deem inappropriate trial determine investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Tenofovir Disoproxil Fumarate</keyword>
	<keyword>4-Aminosalicylic Acid</keyword>
	<keyword>Tuberculosis</keyword>
	<keyword>HIV</keyword>
</DOC>